(Updated - March 6, 2026 6:18 AM EST)

Barclays analyst Luke Sergott upgraded Medpace (NASDAQ: MEDP) from Underweight to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE